Company Overview

Khiron Life Sciences Corp. is a Canadian integrated medical cannabis company with its core operations in Colombia. Khiron combines leading international scientific expertise, agricultural advantages, and branded product market entrance experience to address the unmet medical needs in a market of over 620 million people in Latin America.

view more:

Khiron to commercialize medical cannabis sales in Q3

KHIRON OBTAINS FINAL APPROVAL TO COMMERCIALIZE CBD PRODUCTION AND RECEIVES APPROVAL FOR AN ADDITIONAL 17 CANNABIS STRAINS FROM COLOMBIAN AGRICULTURAL INSTITUTE #KHRN #KHRNF hiron Life Sciences Corp. has received approval from the National Cultivar Registry and the Technical Direction of the ICA for the commercialization of 17 strains of cannabis. The approvals bring the total

Khiron President Chris Naprawa to Participate in Grit Capital Virtual Investor Conference

TORONTO, June 25, 2019  – Khiron Life Sciences Corp. (“Khiron” or the “Company“) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, announces today that Company president Chris Naprawa will be presenting at the Grit Capital Virtual Investor Conference to be hosted on June 26, 2019. Date: Wednesday, June 26, 2019 Time: 1:20pm EST Website Registration Link: This

Khiron Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF

TORONTO, May 29, 2019  – Khiron Life Sciences Corp. (“Khiron” or the “Company“) (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America is pleased to announce today its addition to the MJ ETFMG Alternative Harvest ETF (NYSE:MJ) (the “Fund”), a fund with approximately US$1.22 billion in assets currently under management. This represents an important development for

Khiron Life Sciences Hires Management Team to Lead Dixie Brands Joint Venture and Continue Market Expansion Strategy in Chile and Mexico

“We are excited to announce such a talented team will be joining Khiron as we continue to expand our market initiatives across various jurisdictions in Latin America.” #KHRN #KHRNF #DIXI #DXBR   Seasoned capital markets leader and cannabis authority John Cooke is appointed VP of Corporate Development Luis Chavas to manage corporate development strategy and guide regulatory affairs for